Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

American Journal of Medical Genetics, Part A

Volumn 149, Issue 7, 2009, Pages 1399-1406

  Werler, Martha M ^a   Mitchell, Allen A ^a   Moore, Cynthia A ^b   Honein, Margaret A ^b  

^a BOSTON UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Gastroschisis; Medications; Pregnancy; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT; DECONGESTIVE AGENT; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; BLOOD VESSEL FUNCTION; CASE CONTROL STUDY; COLLEGE; CONTROLLED STUDY; FEMALE; GASTROSCHISIS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SMOKING; MEDICAL RECORD REVIEW; OBESITY; PATHOGENESIS; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GASTROSCHISIS; HUMANS; INFANT; MATERNAL AGE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING; VASCULAR DISEASES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; YOUNG ADULT;

EID: 67649890571     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32897     Document Type: Article

References (32)

1. Byron-Scott R, Haan E, Chan A, Bower C, Scott H, Clark K. 1998. A population-based study of abdominal wall defects in South Australia and Western Australia. Paediatr Perinat Epidemiol 12:136-151.
2. Connor TJ. 2004. Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): A stressor on the immune system. Immunology 111:357-367.
3. deVries PA. 1980. The pathogenesis of gastroschisis and omphalocele. J Pediatr Surg 15:245-251.
4. Draper ES, Rankin J, Tonks AM, Abrams KR, Field DJ, Clarke M, Kurinczuk JJ. 2008. Recreational drug use: A major risk factor for gastroschisis? Am J Epidemiol 167:485-491.
5. Drongowski RA, Smith RK, Coran AG, Klein MD. 1991. Contribution of demographic and environmental factors to the etiology of gastroschisis: A hypothesis. Fetal Diagn Ther 6:14-27.
6. Feldkamp ML, Carey JC, Sadler TW. 2007. Development of gastroschisis: Review of hypotheses, a novel hypothesis, and implications for research. Am J Med Genet Part A 143A:639-652.
7. Feldkamp ML, Alder SC, Carey JC. 2008a. A case control population- based study investigating smoking as a risk factor for gastroschisis in Utah, 1997-2005. Birth Defects Res A Clin Mol Teratol 82:768-775.
8. Feldkamp ML, Reefhuis J, Kucik J, Krikov S, Wilson A, Moore CA, Carey JC, Botto LD. 2008b. Case-control study of self-reported genitourinary infections and risk of gastroschisis: Findings from the National Birth Defects Prevention Study, 1997-2003. Br Med J 336:1420-1423.
9. Goldbaum G, Daling J, Milham S. 1990. Risk factors for gastroschisis. Teratology 42:397-403.
10. Haddow JE, Palomaki GE, Holman MS. 1993. Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology 47:225-228.
11. Hoyme HE, Higginbottom MC, Jones KL. 1981. The vascular pathogenesis of gastroschisis: Intrauterine interruption of the omphalomesenteric artery. J Pediatr 98:228-231.
12. Hoyme HE, Jones MC, Jones KL. 1983. Gastroschisis: Abdominal wall disruption secondary to early gestational interruption of the omphalomesenteric artery. Semin Perinatol 7:294-298.
13. Hume RF Jr, Gingras JL, Martin LS, Hertzberg BS, O'Donnell K, Killam AP. 1994. Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: Further support for cocaine-induced vascular disruption teratogenesis. Fetal Diagn Ther 9:239-245.
14. Kilic N, Kiristioglu I, Balkan E, Dogruyol H. 2001. Oromandibular limb hypogenesis and gastroschisis. J Pediatr Surg 36:E15.
15. Komuro H, Watanabe M, Matoba K, Kaneko M. 2003. Gastroschisis with omphalomesenteric artery remnant, colonic atresia and arthrogryposis multiplex congenita. Eur J Pediatr Surg 13:334-336.
16. Leitich H. 2005. Secondary predictors of preterm labour. BJOG 112:48-50.
17. Lin S, Munsie JP, Herdt-Losavio ML, Bell E, Druschel C, Romitti PA, Olney R. 2008. Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol 168:73-79.
18. Lynberg MC, Cordero JF, Khoury MJ. 1992. Increasing prevalence at birth of gastroschisis in metropolitan Atlanta, 1968-1990. Teratology 45:453 (abstract).
19. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. 1997. Prenatal exposure to salicylates and gastroschisis: A case-control study. Teratology 56: 241-243.
20. Morrison JJ, Chitty LS, Peebles D, Rodeck CH. 2005. Recreational drugs and fetal gastroschisis: Maternal hair analysis in the peri-conceptional period and during pregnancy. BJOG 112:1022-1025.
21. Reid CO, Hall JG, Anderson C, Bocian M, Carey J, Costa T, Curry C, Greenberg F, Horton W, Jones M, Lafer C, Larson E, Lubinsky M, McGillivray B, Pembry M, Popkin J, Seller M, Siebert V, Verhagen A. 1986. Association of amyoplasia with gastroschisis, bowel atresia, and defects of the muscular layer of the trunk. Am J Med Genet 24:701-710.
22. Robertson WL, Glinksi LP, Kirkpatrick SJ, Pauli RM. 1992. Further evidence that arthrogryposis multiplex congenita in the human sometimes is caused by an intrauterine vascular accident. Teratology 45: 345-351.
23. Shaw A. 1975. The myth of gastroschisis. J Pediatr Surg 10:235-244.
24. Suzuki K, Minei LJ, Johnson EE. 1980. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 136: 1009-1013.
25. Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ. 1994. A population- based study of gastroschisis: Demographic, pregnancy, and lifestyle risk factors. Teratology 50:44-53.
26. Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ. 1996. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54:84-92.
27. Torfs CP, Christianson RE, Iovannisci DM, Shaw GM, Lammer EJ. 2006. Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol 76:723-730.
28. Werler MM, Mitchell AA, Shapiro S. 1992a. First trimester maternal medication use in relation to gastroschisis. Teratology 45:361-367.
29. Werler MM, Mitchell AA, Shapiro S. 1992b. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45:353-360.
30. Werler MM, Sheehan JE, Mitchell AA. 2002. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155: 26-31.
31. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. 2007. Systemic effects of smoking. Chest 131:1557-1566.
32. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Public Health Rep 116:32-40.